EUVIMEDEUVIMED entdecken
Open Access

Superior clinical outcomes in patients with non-small cell lung cancer harboring multiple ALK fusions treated with tyrosine kinase inhibitors

Qi Wei, Yuanyuan Zhang, Yongsheng Wang, Aakash Desai, Sihan Tan, Qin Huang, Xin Pu, Panwen Tian, Yalun Li

Translational Lung Cancer Research · 2023-09 · 12 (9) · 1935-1948

DOI: 10.21037/tlcr-23-484 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Lung Cancer Research, 2023-09. Verfasst von Qi Wei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Precision Medicine Key Laboratory …. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ALK-rearrangedMultiple anaplastic lymphoma kinase fusions (multiple ALK fusions)distribution of ALK fusionsprognosissingle ALK fusion

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu,…
  • Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Thoracic Oncology Ward, Department of Medical Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA.

Zitieren

APA

Wei, Q., Zhang, Y., Wang, Y., Desai, A., Tan, S., Huang, Q., Pu, X., Tian, P., & Li, Y. (2023). Superior clinical outcomes in patients with non-small cell lung cancer harboring multiple ALK fusions treated with tyrosine kinase inhibitors. Translational Lung Cancer Research, 12(9), 1935-1948. https://doi.org/10.21037/tlcr-23-484

Vancouver

Wei Q, Zhang Y, Wang Y, Desai A, Tan S, Huang Q, et al. Superior clinical outcomes in patients with non-small cell lung cancer harboring multiple ALK fusions treated with tyrosine kinase inhibitors. Translational Lung Cancer Research. 2023;12(9):1935-1948. doi:10.21037/tlcr-23-484

BibTeX
@article{Wei2023,
  author = {Wei, Qi and Zhang, Yuanyuan and Wang, Yongsheng and Desai, Aakash and Tan, Sihan and Huang, Qin and Pu, Xin and Tian, Panwen and Li, Yalun},
  title = {Superior clinical outcomes in patients with non-small cell lung cancer harboring multiple ALK fusions treated with tyrosine kinase inhibitors},
  journal = {Translational Lung Cancer Research},
  year = {2023},
  volume = {12},
  number = {9},
  pages = {1935--1948},
  doi = {10.21037/tlcr-23-484}
}
Kostenlos starten →